TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | 5 | 14 | 13 | -14 | -10 | 2 |
| P | %wins | 100 | 100 | 100 | 100 | 33 | 33 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/05 11:27 | 11/3/05 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Fahim Raafat E F | FL | O | SVP Tech | P | 17 | 3.46 | 24 | 5 | 73 | 12 | D | -70 | -76 | -70 | -77 | -75 | -72 | -71 | -6 | 2 | 0 | 7 | 18 | 103 | 84 |
6/10/05 09:37 | 6/8/05 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Fahim Raafat E F | FL | O | SVP Tech | P | 24 | 12.15 | 7 | 2 | 55 | 6 | D | 76 | -18 | -16 | 7 | 15 | 0 | 0 | 0 | 1 | 15 | 20 | 10 | -71 | -58 |
5/23/05 16:31 | 5/20/05 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Fahim Raafat E F | FL | O | SVP Tech | P | 12 | 12.17 | 5 | 1 | 38 | 4 | D | 76 | -27 | -16 | -7 | 0 | 13 | 8 | 5 | 2 | 0 | 16 | 12 | -75 | -57 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |